Harmony Biosciences

At Harmony Biosciences, we are dedicated to developing and delivering innovative therapies for people living with rare neurological diseases who have unmet medical needs. Our commitment to pursue innovative and novel treatments extends beyond clinical endpoints. We aim to address real-world patient needs with potential first-in-class and best-in-class therapies. We believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we nurture. Harmony Biosciences’ culture is defined by our core values – keeping patients at the heart of all we do, acting with integrity and ethics, working with a one-team attitude, leading with the science as we identify clinical possibilities, and delivering excellence.

Company Ownership: Public Stock Symbol: HRMY

LEADERSHIP
CEO: Jeff M. Dayno, MD